Furthermore, another GC–MS metabolomic study with pathway enrichment analysis followed by qPCR examination of specific gene expression reported that DAO was a candidate gene in the progression of cirrhosis to HCC. This evidence concerns the gene DAO and hepatocellular carcinoma.